Pirbright shares in global vaccines fund
The Pirbright Institute is to share in a £6.3m fund for five Global Vaccines Networks.
The Pirbright Institute is to share in a £6.3m fund for five Global Vaccines Networks.
The Pirbright Institute is to work with scientific partners to establish a centre where experts tackle diseases spread by insects, ticks and mites.
An international agreement designed to share the benefits of genetic resources is presenting ‘significant logistical challenges’ to the control of transboundary livestock diseases, according to specialist researchers.
The 2010 Nagoya Protocol on Access and Benefit Sharing, implemented in 2014, is intended to ensure the benefits that arise from the use of genetic material, such as the development of vaccines and medicines that are essential to control diseases, are shared in a fair and equitable way.
® The Pirbright Institute 2024 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.